1,647 results on '"Futreal P"'
Search Results
2. Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
3. Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer
4. Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models
5. METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
6. Intratumoral microbiome of adenoid cystic carcinomas and comparison with other head and neck cancers
7. Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
8. Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases
9. Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
10. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
11. Whole genome DNA copy number changes identified by high density oligonucleotide arrays
12. The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
13. Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
14. Epigenomic and Transcriptomic Profiling of Solitary Fibrous Tumors Identifies Site-Specific Patterns and Candidate Genes Regulated by DNA Methylation
15. ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma
16. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
17. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
18. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma
19. Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance
20. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis
21. Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma
22. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
23. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
24. Structural variants drive context-dependent oncogene activation in cancer
25. Netie: inferring the evolution of neoantigen–T cell interactions in tumors
26. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non–Small Cell Lung Cancer
27. Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
28. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
29. Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL
30. Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
31. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment
32. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
33. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
34. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
35. Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
36. Patient–reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia
37. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
38. Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma
39. TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
40. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure
41. Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAFV600E inhibition resistance in melanoma
42. Multi-modal molecular programs regulate melanoma cell state
43. Multi-site desmoplastic small round cell tumors are genetically related and immune-cold
44. Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
45. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
46. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
47. Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association
48. Clonal evolution of hematopoietic stem cells after cancer chemotherapy
49. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation
50. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.